Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

GUARNOTTA, Valentina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.710
EU - Europa 2.433
AS - Asia 1.247
SA - Sud America 199
AF - Africa 44
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.640
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.682
IT - Italia 1.021
CN - Cina 554
SG - Singapore 488
DE - Germania 376
FI - Finlandia 284
BR - Brasile 166
IE - Irlanda 151
UA - Ucraina 137
GB - Regno Unito 120
FR - Francia 72
RU - Federazione Russa 59
SE - Svezia 57
TR - Turchia 42
IN - India 34
BE - Belgio 32
NL - Olanda 32
KR - Corea 28
AT - Austria 25
RO - Romania 23
HK - Hong Kong 22
MX - Messico 18
IQ - Iraq 17
CI - Costa d'Avorio 16
MA - Marocco 10
PL - Polonia 10
UZ - Uzbekistan 10
GR - Grecia 7
IR - Iran 7
PE - Perù 7
AR - Argentina 5
CA - Canada 5
CH - Svizzera 5
CO - Colombia 5
DK - Danimarca 5
EC - Ecuador 5
ES - Italia 5
KE - Kenya 5
TW - Taiwan 5
ZA - Sudafrica 5
NP - Nepal 4
VE - Venezuela 4
VN - Vietnam 4
AU - Australia 3
AZ - Azerbaigian 3
BD - Bangladesh 3
CZ - Repubblica Ceca 3
EG - Egitto 3
JP - Giappone 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
IL - Israele 2
LB - Libano 2
LT - Lituania 2
MK - Macedonia 2
MY - Malesia 2
PH - Filippine 2
PK - Pakistan 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CL - Cile 1
ET - Etiopia 1
EU - Europa 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 9.640
Salva come PNG Salva come JPEG
Città #
Fairfield 886
Ashburn 523
Houston 478
Woodbridge 446
Chandler 393
Wilmington 376
Seattle 374
Cambridge 278
Singapore 260
Ann Arbor 249
Palermo 160
Medford 159
Dublin 148
Munich 105
Princeton 99
Altamura 96
Des Moines 94
Nanjing 86
Jacksonville 68
Lawrence 63
San Diego 55
Beijing 51
Helsinki 49
Ludwigshafen am Rhein 49
Santa Clara 48
Boardman 45
Dearborn 43
New York 42
London 38
Rome 37
Milan 35
Nanchang 35
Jinan 34
Brussels 31
Changsha 30
Izmir 29
Shenyang 29
Hebei 28
Tulsa 27
Ningbo 25
Jiaxing 23
Tianjin 23
Phoenix 22
Redwood City 22
Falls Church 18
Nuremberg 18
Zhengzhou 18
Guangzhou 17
Abidjan 16
Bucheon-si 14
Council Bluffs 14
Saint Petersburg 14
São Paulo 14
Hangzhou 13
San Paolo di Civitate 13
Haikou 12
Hong Kong 12
Kumar 12
Columbus 11
Frankfurt 11
Frankfurt am Main 11
Lappeenranta 11
Los Angeles 11
Norwalk 11
Pune 11
Rio de Janeiro 11
Seongnam 11
Taizhou 11
Atlanta 10
Düsseldorf 10
Amsterdam 9
Central 9
Chicago 9
Falkenstein 9
Kunming 9
Napoli 9
Taiyuan 9
Vienna 9
Auburn Hills 8
The Dalles 8
Venice 8
Bari 7
Bremen 7
Dallas 7
Den Haag 7
Lima 7
Orange 7
Washington 7
Hefei 6
Kilburn 6
Verona 6
West Jordan 6
Atripalda 5
Cagliari 5
Erbil 5
Nairobi 5
Taipei 5
Tashkent 5
Bologna 4
Casablanca 4
Totale 6.733
Salva come PNG Salva come JPEG
Nome #
The Daily Consumption of Cola Can Determine Hypocalcemia: A Case Report of Postsurgical Hypoparathyroidism-Related Hypocalcemia Refractory to Supplemental Therapy with High Doses of Oral Calcium 334
Valutazione dell’insulino-sensibilità tramite clamp euglicemico iperinsulinemico in bambini in terapia sostitutiva con GH. 286
COLORECTAL CANCER IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A SINGLE-CENTRE EXPERIENCE. 266
Predictors of microvascular complications in type 1 diabetic patients at onset: The role of metabolic memory 223
NANOG plays a hierarchical role in the transcription network regulating the pluripotency and plasticity of adipose tissue-derived stem cells 185
The degree of urinary hypercortisolism is not correlated with the severity of cushing’s syndrome 184
Superior mesenteric artery syndrome: Clinical, endoscopic, and radiological findings 172
Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency 171
Comparison between euglycemic hyperinsulinemic clamp and surrogate indices of insulin sensitivity in children with growth hormone deficiency 167
Hepatic steatosis index in acromegaly: Correlation with insulin resistance regardless of the disease control 167
Correlation between adrenal function, growth hormone secretion, and insulin sensitivity in children with idiopathic growth hormone deficiency 162
Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia in acromegaly with severe visceromegaly and divergence between growth hormone and insulin-like growth factor-1 concentrations during the follow-up: causal or casual association? 161
Is diabetes in Cushing's syndrome only a consequence of hypercortisolism? 157
Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels. 155
Development of a fuzzy expert system for the control of glycemia in type 1 diabetic patients 151
Anti-Inflammatory Action of Heterogeneous Nuclear Ribonucleoprotein A2/B1 in Patients with Autoimmune Endocrine Disorders 151
The visceral adiposity index is associated with insulin sensitivity and IGF-I levels in adults with growth hormone deficiency 141
Circulating Irisin Levels in Children with GH Deficiency before and after 1 Year of GH Treatment 141
Resistin, visfatin, leptin and omentin are differently related to hormonal and metabolic parameters in growth hormone-deficient children 140
Improved insulin sensitivity and secretion in prediabetic patients with adrenal insufficiency on dual-release hydrocortisone treatment: a 36-month retrospective analysis 137
Correlation between Severity of Growth Hormone Deficiency and Thyroid Metabolism and Effects of Long-Term Growth Hormone Treatment on Thyroid Function in Children with Idiopathic Growth Hormone Deficiency. 136
Immune checkpoint blockade for Merkel cell carcinoma: actual findings and unanswered questions 136
Efficacy of combined treatment with pasireotide, pegvisomant and cabergoline in an acromegalic patient resistant to other treatments: a case report 129
Growth hormone and hematopoiesis: A retrospective analysis on a large cohort of children with growth hormone deficiency 129
No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus. 129
The treatment of hyperinsulinemic hypoglycaemia in adults: an update 127
The metabolic outcomes of growth hormone treatment in children are gender specific 125
Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment. 123
Insulin sensitivity and secretion and adipokine profile in patients with Cushing’s disease treated with pasireotide 123
Relationship between body fat distribution and blood disorders in patients with visceral obesity with and without diabetes mellitus 122
Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal-Dystrophy (APECED) in Sicily: confirmation that R203X is the peculiar AIRE gene mutation. 121
NEW THERAPEUTIC PERSPECTIVES IN IRRITABLE BOWEL SYNDROME: TARGETING LOW-GRADE INFLAMMATION, IMMUNO-NEUROENDOCRINE AXIS, MOTILITY, SDECRETION AND BEYOND 120
Higher cardiometabolic risk in idiopathic versus autoimmune type 1 diabetes: A retrospective analysis 120
Pasireotide treatment reduces cardiometabolic risk in Cushing’s disease patients: an Italian, multicenter study 120
Clinical and hormonal characteristics in heterozygote carriers of congenital adrenal hyperplasia 119
Efficacy and safety of everolimus in extrapancreatic neuroendocrine tumor: A comprehensive review of literature 117
The Zollinger-Ellison syndrome: is there a role for somatostatin analogues in the treatment of the gastrinoma? 115
Pasireotide versus pituitary surgery: a retrospective analysis of 12 months of treatment in patients with Cushing's disease 113
The medical treatment with pasireotide in Cushing’s disease: an Italian multicentre experience based on “real-world evidence” 113
Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients. 112
Therapeutic sequences in patients with grade 1−2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group 102
Off-line control of the postprandial glycemia in type 1 diabetes patients by a fuzzy logic decision support 99
Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing’s Disease 99
Body composition assessment for the definition of cardiometabolic risk. 98
EFFECTS OF PASIREOTIDE TREATMENT ON CARDIOMETABOLIC RISK IN PATIENTS WITH CUSHING’S DISEASE : AN ITALIAN, MULTICENTER STUDY 98
Sviluppo di un sistema di supporto decisionale tipo Fuzzy per il controllo della glicemia post-prandiale nel diabete mellito tipo 1 97
Improved cardiovascular and cardiometabolic risk in patients with type 1 diabetes and autoimmune polyglandular syndrome switched from glargine to degludec due to hypoglycaemic variability 95
Impact of atorvastatin plus n-3 PUFA on metabolic, inflammatory and coagulative parameters in metabolic syndrome without and with type 2 diabetes mellitus 93
Dual-release hydrocortisone improves hepatic steatosis in patients with secondary adrenal insufficiency: A real-life study 90
Effects of pasireotide treatment on coagulative profile: a prospective study in patients with Cushing’s disease 89
The adipose visceral dysfunction plays an important role in diabetes in Cushing disease. 82
Traitement séquential avec des corticostéroides dans les ophtalmopathy Graves 80
Efficacia della associazione Atorvastatina e n-3 PUFA in pazienti affetti da dislipidemia combinata e ad alto rischio di eventi cardiovascolari 78
IPOVITAMINOSI D ED EFFETTI BENEFICI DELLA TERAPIA SOSTITUTIVA CON GH SUI LIVELLI DI VITAMINA D IN BAMBINI AFFETTI DA DEFICIT DI GH 77
More favorable metabolic impact of three-times-weekly versus daily growth hormone (GH) treatment in naïve GH-deficient children 76
Effetti a lungo termine del trattamento con Simvastatina ed Ezetimibe sui livelli di HDL-C e hs-PCR in pazienti affetti da Ipercolesterolemia familare(FH) con pregresso IMA e/o Lesione carotidea 75
Utilizzo del Visceral Adiposity Index per l’identificazione di donne con sindrome iperandrogenica a rischio cardiometabolico. 75
Alte dosi di cabergolina migliorano i parametri metabolici in pazienti affetti da prolattinoma. 75
Maggiore rischio cardiometabolico in pazienti di razza non caucasica affetti da diabete mellito di tipo 1 idiopatico rispetto alla forma autoimmune in pazienti caucasici. 75
Glucocorticoid excess and COVID-19 disease 75
Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia, severe visceromegaly and divergence between growth hormone and insulin-like growth factor-1 concentrations in acromegaly due to a therapeutically resistant pituitary GH-secreting macroadenoma 72
ENDOCRINE TUMOURS: Calcitonin in thyroid and extra-thyroid neuroendocrine neoplasms: the two-faced Janus. 72
Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia 71
Alta prevalenza di Sindrome dell’ovaio policistico in donne diabetiche di tipo 1 in età fertile. 68
Circulating adipokine levels in diabetic patients with Cushing disease on pasireotide treatment compared with patients with type 2 diabetes mellitus 66
GH-treatment improves growth and reduces the severity of fibrosis and hypertansaminasemia in a prepubertal child with sclerosant cholangiopathy 64
Maggior rischio cardiometabolico nelle donne affette da Cushing, anche in assenza di una franca Sindrome Metabolica. 64
Miglioramento clinico e metabolico in pazienti affetti da diabete mellito tipo 1 associato ad altre endocrinopatie (APS) dopo shift della terapia insulinica basale con glargine a degludec 64
INSULIN SECRETION AND SENSITIVITY DURING PASIREOTIDE TREATMENT IN PATIENTS WITH RECURRENT CUSHING DISEASE: A CASE SERIES 63
Comparison of clinical and metabolic effects of pasireotide and pituitary surgery in Cushing disease 62
Insulin sensitivity and visceral adiposity index (VAI) in women with functional secondary amenorrhea. 60
IL CONSUMO DI BEVANDE RICCHE DI ACIDO ORTOFOSFORICO COME FATTORE DI RISCHIO PER LO SVILUPPO DI IPOCALCEMIA: IL CASO DI UNA DONNA CON IPOPARATIROIDISMO POST-CHIRURGICO 59
Effects of GLP-1 receptor agonists on myokine levels and pro-inflammatory cytokines in patients with type 2 diabetes mellitus 57
CONVENTIONAL GLUCOCORTICOID REPLACEMENT THERAPY VS. DUAL-RELEASE HYDROCORTISONE: EFFECTS ON INFLAMMATION AND IMMUNE PROFILE IN PATIENTS WITH PRIMARY ADRENAL INSUFFICIENCY AND IMPLICATIONS OF THERAPY RESPONSE PREDICTORS 56
Clinical and metabolic impact of three-times-weekly versus daily growth hormone (GH) treatment in naïve GH-deficient children 55
Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily. 52
Poor diagnostic value of the euglycemic-hyperinsulinemic clamp in the clinical assessment of insulin resistant women with PCOS. 51
Levothyroxine and insulin requirement in autoimmune polyglandular type 3 syndrome: a real-life study 51
COVID-19 and the Pancreas: A Narrative Review 47
Microbiota Gut-Brain Axis in Ischemic Stroke: A Narrative Review with a Focus about the Relationship with Inflammatory Bowel Disease. 45
Valutazione dell’insulino-sensibilità e della funzione adiposa viscerale nel diabete mellito tipo 1 autoimmune ed idiopatico. 44
Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers. 44
Modificazioni di insulino-secrezione, insulino-sensibilità e funzione adiposa durante terapia con pasireotide in un gruppo di pazienti con malattia di Cushing 42
Predictive factors of polycystic ovary syndrome in girls with precocious pubarche 42
LONG-TERM METABOLIC EFFECTS OF GH THERAPY IN CHILDREN WITH IDIOPATHIC GH DEFICIENCY 40
Correction to: One Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diabetes Mellitus 39
Ultrasound Parameters Can Accurately Predict the Risk of Malignancy in Patients with "Indeterminate TIR3b" Cytology Nodules: A Prospective Study 37
IS THE DEGREE OF URINARY FREE CORTISOL AN EXHAUSTIVE PARAMETER FOR DEFINING CUSHING SYNDROME SEVERITY? 37
Miglioramento dell'insulino-sensibilità e dell'insulino-secrezione dopo switch da terapia con glucocorticoidi tradizionali a idrocortisone "dual release" in pazienti affetti da iposurrenalismo 37
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? 37
Diabetic foot ulcers: Retrospective comparative analysis from Sicily between two eras 37
Thyroid function during long-term GH treatment in children affected by idiopathic GH deficiency 36
Emerging therapies in pheochromocytoma and paraganglioma: Immune checkpoint inhibitors in the starting blocks 36
EFFECT OF SWITCH FROM CONVENTIONAL GLUCOCORTICOIDS TO “DUAL RELEASE HYDROCORTISONE” (DR-HC) ON METABOLIC PROFILE AND QUALITY OF LIFE IN ADULT PATIENTS WITH SECONDARY ADRENAL INSUFFICIENCY (SAI): RESULTS OF THREE MONTHS FOLLOW-UP 35
GENOMIC AND PROTEOMIC EVALUATION OF VISCERAL AND SUBCUTANEOUS ADIPOSE DERIVED STEM CELLS AND FUNCTIONAL ROLES OF PLURIPOTENCY TRANSCRIPTION FACTORS 35
Metabolic comorbidities of adrenal insufficiency: Focus on steroid replacement therapy and chronopharmacology. 35
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective. 35
One Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diabetes Mellitus 33
Myoinositol supplementation in the treatment of gestational diabetes mellitus: effects on glycaemic control and maternal-foetal outcomes 32
Revaluation of the clinical and metabolic behavior of GHD children during GH treatment according to newly proposed note 39 of the Italian Medicines Agency (AIFA) 32
Totale 9.772
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.779
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020432 0 0 0 0 0 0 0 0 0 120 243 69
2020/20211.162 76 67 84 88 91 90 93 103 137 98 108 127
2021/20221.166 39 168 41 62 45 59 46 65 199 161 55 226
2022/20231.364 146 261 22 122 139 190 75 111 188 8 68 34
2023/2024720 26 99 29 64 56 170 103 49 10 26 17 71
2024/20251.512 68 127 132 202 54 99 161 244 188 237 0 0
Totale 10.363